Five-year follow-up of a phase I trial of donor-derived modified immune cell infusion in kidney transplantation

BACKGROUND: The administration of modified immune cells (MIC) before kidney transplantation led to specific immunosuppression against the allogeneic donor and a significant increase in regulatory B lymphocytes. We wondered how this approach affected the continued clinical course of these patients. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Schaier, Matthias, Morath, Christian, Wang, Lei, Kleist, Christian, Opelz, Gerhard, Tran, Thuong Hien, Scherer, Sabine, Pham, Lien, Ekpoom, Naruemol, Süsal, Caner, Ponath, Gerald, Kälble, Florian, Speer, Claudius, Benning, Louise, Nusshag, Christian, Mahler, Christoph F., Pego da Silva, Luiza, Sommerer, Claudia, Hückelhoven-Krauss, Angela, Czock, David, Mehrabi, Arianeb, Schwab, Constantin, Waldherr, Rüdiger, Schnitzler, Paul, Merle, Uta, Schwenger, Vedat, Krautter, Markus, Kemmner, Stephan, Fischereder, Michael, Stangl, Manfred, Hauser, Ingeborg A., Kälsch, Anna-Isabelle, Krämer, Bernhard K., Böhmig, Georg A., Müller-Tidow, Carsten, Reiser, Jochen, Zeier, Martin, Schmitt, Michael, Terness, Peter, Schmitt, Anita, Daniel, Volker
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10361653/
https://www.ncbi.nlm.nih.gov/pubmed/37483623
http://dx.doi.org/10.3389/fimmu.2023.1089664

Ejemplares similares

Ejemplares similares